Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000813926 | SCV000954310 | benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001825634 | SCV002533564 | likely benign | Dyskeratosis congenita | 2022-01-03 | criteria provided, single submitter | curation | |
Revvity Omics, |
RCV003132082 | SCV003814322 | uncertain significance | not provided | 2020-11-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003132082 | SCV005376660 | uncertain significance | not provided | 2023-10-19 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Natera, |
RCV001825634 | SCV002095508 | benign | Dyskeratosis congenita | 2020-02-02 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004538117 | SCV004748153 | likely benign | RTEL1-related disorder | 2022-09-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |